Evidence map›Paper›PMID 41999563›Full record

ReviewHeart failure reviews2026

Digital heart failure management: Insights from the COPILOT study.

Jonas M Rolland, Tarjei Øvrebotten, Kevin Damman, Stephen J Greene, Peder L Myhre

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heart failure reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jonas M RollandDepartment of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Tarjei ØvrebottenDepartment of Cardiology, Akershus University Hospital, Lørenskog, Norway.
Kevin DammanDepartment of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Stephen J GreeneDivision of Cardiology, Duke University School of Medicine, Durham, NC, USA.
Peder L MyhreDepartment of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway. p.l.myhre@medisin.uio.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Suboptimal implementation of guideline-directed medical therapy (GDMT) remains a major problem in heart failure (HF) care. The Cooperative Program for Implementation of Optimal Therapy in Heart Failure (COPILOT-HF) trial evaluated an innovative remote strategy to optimize GDMT across the spectrum of HF, irrespective of left ventricular ejection fraction (LVEF). This pragmatic randomized study compared a pharmacist-led, navigator-assisted remote program against traditional provider notification and education. The results, recently presented at the American Heart Association 2025 Scientific Sessions, offer compelling insights into overcoming clinical inertia and improving HF management in the digital age. This mini review examines the trial’s key findings and their potential to reshape HF care delivery.

Indexed as

Disease ManagementGuideline AdherenceHeart FailureDigital HealthHumansPractice Guidelines as TopicStroke VolumeTelemedicineGuideline adherenceHeart failureMedication adherenceTelemedicine

Identifiers

PMID41999563
PMCPMC13091802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.